DNA-based Influenza Vaccine in the Elderly

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

March 31, 2015

Conditions
Influenza, HumanOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract InfectionsRespiratory Tract Diseases
Interventions
BIOLOGICAL

FVH1 - a DNA-based influenza vaccine

0.9 mg FVH1 vaccine

Trial Locations (1)

R3A 1R9

MS Building Health Sciences Centre, Winnipeg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Inovio Pharmaceuticals

INDUSTRY

lead

University of Manitoba

OTHER

NCT01587131 - DNA-based Influenza Vaccine in the Elderly | Biotech Hunter | Biotech Hunter